05/21/2024
8:20 PM | Bradbury Strategic Investment Fund A (0002022777) (Filed by)
IGC Pharma (Subject)
| Form SC 13D | |
05/13/2024
8:53 PM | Bradbury Strategic Investment Fund A (0002022777) (Reporting)
IGC Pharma (Issuer)
| Form 3
Initial statement of beneficial ownership of securities | |
05/13/2024
8:54 PM | Bradbury Strategic Investment Fund A (0002022777) (Reporting)
IGC Pharma (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/02/2024
11:15 PM | IGC Pharma (Filer)
| Form EFFECT | |
04/05/2024
10:33 AM | IGC Pharma (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
03/15/2024
8:27 PM | GRIMALDI CLAUDIA (Reporting)
IGC Pharma (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/15/2024
8:05 PM | IGC Pharma (Issuer)
Moran James P (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
|
03/15/2024
8:09 PM | IGC Pharma (Issuer)
PRINS RICHARD K (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/15/2024
7:32 PM | IGC Pharma (Subject)
MUKUNDA RAM (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
03/15/2024
4:34 PM | IGC Pharma (Issuer)
LIERMAN TERRY L (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/13/2024
8:00 AM | IGC Pharma (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
03/12/2024
4:09 PM | IGC Pharma (Issuer)
LIERMAN TERRY L (Reporting)
| Form 3
Initial statement of beneficial ownership of securities | |
01/08/2024
11:15 PM | IGC Pharma (Filer)
| Form EFFECT | |
11/09/2023
4:15 PM | IGC Pharma (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
10/27/2023
4:21 PM | IGC Pharma (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
10/27/2023
3:38 PM | IGC Pharma (Filer)
| Form 424B5 | |
10/05/2023
11:15 PM | IGC Pharma (Filer)
| Form EFFECT | |
09/29/2023
4:23 PM | IGC Pharma (Filer)
| Form S-3
Registration statement under Securities Act of 1933 | |
08/21/2023
11:44 AM | IGC Pharma (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
07/07/2023
3:15 PM | IGC Pharma (Filer)
| Form 10-K
Annual report pursuant to Section 13 or 15(d) | |
07/07/2023
10:41 AM | IGC Pharma (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
06/28/2023
8:25 PM | GRIMALDI CLAUDIA (Reporting)
IGC Pharma (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/28/2023
12:46 PM | IGC Pharma (Issuer)
Moran James P (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/27/2023
7:20 PM | IGC Pharma (Issuer)
PRINS RICHARD K (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/27/2023
5:10 PM | IGC Pharma (Issuer)
MUKUNDA RAM (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
